For several years cell therapies have been commanding the headlines with their novel scientific approach and remarkable results in improving patient outcomes. The allure of cell therapy has raised expectations not only for what it could do from a patient standpoint but also how it could potentially transform the way we think about treating and curing patients with life-threatening diseases.

This has led to hundreds of millions of dollars of investment in research-stage cell therapy companies as well as a multitude of partnerships and acquisitions with the expectation of yielding significant clinical and commercial benefits.

The article below highlights a few standout keys to value that cell therapy leadership teams will have to navigate in a best-in class manner despite an arena with a high degree of complexity and uncertainty.

Download this article.